NYSE:A - Agilent Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $112.09
  • Forecasted Upside: -22.70 %
  • Number of Analysts: 24
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 20 Buy Ratings
  • 0 Strong Buy Ratings
$145.01
▼ -1.91 (-1.30%)
1 month | 3 months | 12 months
Get New Agilent Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for A and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for A

Average Price Target: $112.09
▼ -22.70% Downside Potential
This price target is based on 24 analysts offering 12 month price targets for Agilent Technologies in the last 3 months. The average price target is $112.09, with a high forecast of $160.00 and a low forecast of $30.70. The average price target represents a -22.70% upside from the last price of $145.01.

Buy

The current consensus among 24 polled investment analysts is to buy stock in Agilent Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/28/2019
  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/27/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/25/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 7 hold ratings
  • 0 sell ratings
9/23/2020
  • 0 strong buy ratings
  • 17 buy ratings
  • 8 hold ratings
  • 0 sell ratings
12/22/2020
  • 0 strong buy ratings
  • 20 buy ratings
  • 8 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 20 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/21/2021
  • 0 strong buy ratings
  • 20 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 20 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/26/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price TargetBuy$150.00 ➝ $160.00High
5/26/2021KeyCorpBoost Price TargetOverweight$148.00 ➝ $157.00High
5/26/2021SVB LeerinkBoost Price TargetOutperform$140.00 ➝ $145.00High
5/26/2021Wells Fargo & CompanyBoost Price TargetOverweight$140.00 ➝ $150.00High
5/26/2021Robert W. BairdBoost Price TargetOutperform$137.00 ➝ $144.00High
5/26/2021CitigroupBoost Price TargetBuy$150.00 ➝ $160.00High
5/13/2021Canaccord GenuityUpgradeHold ➝ Buy$85.00 ➝ $100.00Low
5/3/2021Canaccord GenuityBoost Price TargetHold$80.00 ➝ $85.00Low
3/19/2021Redburn PartnersUpgradeNeutral ➝ BuyLow
3/18/2021CitigroupUpgradeNeutral ➝ Buy$150.00Medium
3/18/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellUpgradeNeutral ➝ Buy$135.00 ➝ $150.00Medium
2/17/2021KeyCorpBoost Price Target$130.00 ➝ $148.00Low
2/17/2021CitigroupBoost Price Target$120.00 ➝ $135.00Low
2/17/2021Robert W. BairdBoost Price TargetOutperform$133.00 ➝ $137.00Low
2/17/2021Wells Fargo & CompanyBoost Price TargetOverweight$120.00 ➝ $140.00Low
2/17/2021CowenBoost Price TargetOutperform$125.00 ➝ $135.00Low
2/17/2021SVB LeerinkBoost Price TargetOutperform$130.00 ➝ $140.00Low
2/17/2021Bank of AmericaUpgradeNeutral ➝ Buy$147.00Low
1/12/2021MizuhoInitiated CoverageBuy$51.00Medium
12/23/2020MKM PartnersInitiated CoverageBuy$57.00N/A
12/15/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$49.00Low
12/10/2020SVB LeerinkBoost Price TargetOutperform$120.00 ➝ $130.00High
12/3/2020Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
12/2/2020The Goldman Sachs GroupInitiated CoverageBuy$130.00Low
11/25/2020UBS GroupUpgradeNeutral ➝ Buy$103.00 ➝ $132.00Low
11/24/2020JPMorgan Chase & Co.Boost Price TargetOverweight$110.00 ➝ $125.00High
11/24/2020Wells Fargo & CompanyBoost Price TargetOverweight$105.00 ➝ $120.00High
11/24/2020Robert W. BairdBoost Price TargetOutperform$104.00 ➝ $118.00High
11/24/2020SVB LeerinkBoost Price TargetOutperform$100.00 ➝ $120.00High
11/17/2020Cleveland ResearchUpgradeNeutral ➝ BuyLow
11/9/2020KeyCorpInitiated CoverageOverweight$130.00High
11/9/2020HSBCUpgradeHold ➝ Buy$30.70High
11/3/2020Morgan StanleyUpgradeEqual Weight ➝ OverweightLow
9/30/2020Atlantic SecuritiesInitiated CoverageNeutral$105.00Low
8/25/2020Stifel NicolausLower Price TargetHold$39.00 ➝ $37.00Low
8/19/2020Bank of AmericaBoost Price TargetNeutral$99.00 ➝ $103.00Low
8/19/2020Stifel NicolausBoost Price TargetHold$85.00 ➝ $100.00Medium
8/19/2020Jefferies Financial GroupBoost Price TargetBuy$95.00 ➝ $110.00Medium
8/19/2020SVB LeerinkBoost Price TargetOutperform$95.00 ➝ $100.00High
8/19/2020Robert W. BairdBoost Price TargetOutperform$87.00 ➝ $104.00High
8/19/2020Needham & Company LLCReiterated RatingHoldHigh
8/19/2020CitigroupBoost Price TargetNeutral$85.00 ➝ $100.00High
8/19/2020Wells Fargo & CompanyReiterated RatingOverweight$100.00 ➝ $105.00High
7/27/2020Credit Suisse GroupBoost Price TargetNeutral$53.00 ➝ $54.00Medium
7/27/2020Canaccord GenuityBoost Price TargetHold$56.00 ➝ $60.00High
7/20/2020Bank of AmericaBoost Price TargetNeutral$88.00 ➝ $99.00High
7/13/2020The Goldman Sachs GroupInitiated CoverageNeutralHigh
7/2/2020Canaccord GenuityInitiated CoverageHold$56.00Medium
7/1/2020The Goldman Sachs GroupReiterated RatingBuy ➝ NeutralMedium
5/22/2020CfraLower Price TargetHold$89.00 ➝ $85.00Low
5/22/2020Bank of AmericaBoost Price TargetNeutral$74.00 ➝ $88.00Low
5/22/2020UBS GroupBoost Price TargetNeutral$84.00 ➝ $87.00Medium
5/22/2020CowenBoost Price TargetOutperform$80.00 ➝ $95.00Medium
5/22/2020Wells Fargo & CompanyBoost Price TargetOverweight$82.00 ➝ $95.00Low
5/22/2020SVB LeerinkBoost Price TargetOutperform$90.00 ➝ $95.00Low
4/28/2020Royal Bank of CanadaInitiated CoverageSector PerformLow
4/28/2020UBS GroupLower Price TargetNeutral$90.00 ➝ $84.00Low
4/16/2020SunTrust BanksLower Price TargetHold$90.00 ➝ $75.00Low
4/2/2020Stifel NicolausLower Price TargetHold$85.00 ➝ $73.00Medium
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$100.00 ➝ $82.00Low
3/26/2020BarclaysLower Price TargetEqual Weight$85.00 ➝ $76.00Low
3/20/2020CitigroupLower Price TargetNeutral$85.00 ➝ $75.00Medium
2/24/2020Needham & Company LLCDowngradeBuy ➝ Hold$85.00High
2/21/2020CfraLower Price TargetHold$60.00 ➝ $57.00Low
2/19/2020Piper SandlerBoost Price TargetOverweight$86.00 ➝ $96.00Medium
2/19/2020UBS GroupBoost Price TargetBuy ➝ Neutral$87.00 ➝ $90.00High
2/12/2020HSBCUpgradeHold ➝ BuyLow
1/28/2020UBS GroupReiterated RatingBuyLow
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$100.00 ➝ $100.00Medium
1/6/2020CitigroupInitiated CoverageNeutral$85.00Low
1/3/2020Needham & Company LLCInitiated CoverageBuy$77.00Medium
11/26/2019UBS GroupBoost Price TargetNeutral$82.00 ➝ $87.00Low
11/26/2019JPMorgan Chase & Co.Boost Price TargetOverweight$85.00 ➝ $90.00High
11/26/2019Needham & Company LLCReiterated RatingBuy$92.00 ➝ $85.00High
11/14/2019Stifel NicolausInitiated CoverageHold$85.00High
10/18/2019UBS GroupDowngradeBuy ➝ Neutral$82.00Medium
10/9/2019BarclaysLower Price TargetEqual Weight$78.00 ➝ $76.00Low
8/19/2019Needham & Company LLCBoost Price TargetBuy$92.00Low
8/15/2019Robert W. BairdReiterated RatingOutperform$79.00 ➝ $82.00High
8/15/2019Piper Jaffray CompaniesBoost Price TargetOverweight$83.00 ➝ $86.00High
7/16/2019Bank of AmericaDowngradeBuy ➝ Neutral$76.00Low
7/15/2019BarclaysDowngradeOverweight ➝ Equal Weight$86.00 ➝ $78.00Low
6/11/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$83.00Low
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
5/15/2019Bank of AmericaLower Price TargetBuy$88.00 ➝ $82.00High
5/15/2019Deutsche Bank AktiengesellschaftLower Price TargetBuy$90.00 ➝ $85.00High
5/15/2019BarclaysLower Price TargetOverweight$88.00 ➝ $86.00High
3/26/2019CowenBoost Price TargetOutperform ➝ Outperform$80.00 ➝ $90.00Low
3/15/2019UBS GroupInitiated CoverageBuy ➝ Buy$92.00Low
2/25/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$77.00 ➝ $88.00Low
2/21/2019Janney Montgomery ScottReiterated RatingOverweight ➝ Buy$80.00 ➝ $90.00Low
2/21/2019Bank of AmericaReiterated RatingBuy ➝ Buy$78.00 ➝ $87.00Low
2/21/2019BarclaysBoost Price TargetOverweight ➝ Overweight$80.00 ➝ $83.00Low
2/21/2019Deutsche Bank AktiengesellschaftReiterated RatingBuy$90.00Low
2/21/2019JPMorgan Chase & Co.Boost Price TargetOverweight$85.00Medium
2/20/2019Robert W. BairdReiterated RatingBuy$77.00 ➝ $82.00High
2/12/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$80.00 ➝ $85.00Low
1/2/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$77.00High
12/31/2018Alembic Global AdvisorsDowngradeHoldMedium
11/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$86.00 ➝ $89.00Medium
11/12/2018Cleveland ResearchDowngradeBuy ➝ NeutralMedium
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$84.00 ➝ $86.00High
9/18/2018The Goldman Sachs GroupReiterated RatingBuy$77.00 ➝ $82.00Low
9/17/2018The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyLow
8/15/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$77.00 ➝ $80.00Medium
8/15/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$83.00 ➝ $84.00Medium
5/15/2018CowenUpgradeMarket Perform ➝ OutperformHigh
4/11/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$95.00 ➝ $91.00Low
4/9/2018The Goldman Sachs GroupUpgradeNeutral ➝ BuyMedium
4/2/2018Morgan StanleyBoost Price TargetOverweight$90.00 ➝ $95.00High
2/15/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$75.00 ➝ $80.00Low
1/18/2018Robert W. BairdReiterated RatingBuy$76.00Medium
1/8/2018BarclaysReiterated RatingBuy$74.00Low
1/3/2018Evercore ISIInitiated CoverageOutperform$75.00Medium
11/24/2017Robert W. BairdReiterated RatingBuy$72.00N/A
11/22/2017CowenReiterated RatingHold$70.00N/A
11/21/2017BarclaysBoost Price TargetOverweight$67.00 ➝ $71.00N/A
11/21/2017JPMorgan Chase & Co.Boost Price TargetOverweight$75.00N/A
11/21/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$75.00N/A
11/14/2017Morgan StanleyReiterated RatingOverweightN/A
10/20/2017Robert W. BairdReiterated RatingBuy$70.00N/A
9/28/2017CowenReiterated RatingHold$65.00Low
9/26/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$68.00Low
8/16/2017Bank of AmericaBoost Price TargetEqual Weight$66.00 ➝ $68.00Medium
8/16/2017Morgan StanleyReiterated RatingOverweightMedium
8/16/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$66.00 ➝ $68.00Medium
8/16/2017Janney Montgomery ScottBoost Price TargetBuy$65.00 ➝ $70.00Medium
8/16/2017JPMorgan Chase & Co.Reiterated RatingOverweight$70.00Low
8/15/2017Bank of AmericaReiterated RatingEqual WeightMedium
8/9/2017Jefferies Financial GroupReiterated RatingBuy$66.00High
7/19/2017BarclaysReiterated RatingBuy$67.00Low
7/12/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$42.92 ➝ $60.73Low
7/10/2017Morgan StanleyReiterated RatingOverweightLow
6/22/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$66.00Medium
5/24/2017Morgan StanleyBoost Price TargetOverweight$65.00 ➝ $70.00Low
5/24/2017BTIG ResearchBoost Price TargetBuy$57.00 ➝ $65.00Low
5/24/2017Robert W. BairdBoost Price TargetOutperform$57.00 ➝ $62.00Low
5/23/2017Jefferies Financial GroupBoost Price TargetBuy$59.00 ➝ $66.00Low
5/23/2017CowenBoost Price TargetMarket Perform$53.00 ➝ $62.00Medium
5/22/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$58.00 ➝ $62.00Low
4/2/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$56.00 ➝ $58.00Low
3/17/2017Jefferies Financial GroupReiterated RatingBuy$59.00Low
3/15/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$62.00High
2/15/2017UBS GroupBoost Price TargetNeutral$48.00 ➝ $50.00N/A
2/13/2017Janney Montgomery ScottBoost Price TargetBuy$55.00 ➝ $60.00N/A
1/18/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$54.00N/A
1/4/2017CowenDowngradeOutperform ➝ Market Perform$51.00N/A
1/4/2017BarclaysUpgradeEqual Weight ➝ Overweight$48.00 ➝ $51.00N/A
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/A
12/4/2016BTIG ResearchReiterated RatingBuy$55.00N/A
12/4/2016UBS GroupReiterated RatingNeutral$45.00 ➝ $48.00N/A
11/16/2016BTIG ResearchReiterated RatingBuyN/A
11/16/2016UBS GroupReiterated RatingHold$48.00N/A
11/10/2016SVB LeerinkInitiated CoverageOutperform$53.00N/A
10/7/2016Bank of AmericaSet Price TargetBuy$51.00N/A
9/7/2016The Goldman Sachs GroupReiterated RatingBuy$53.00N/A
8/18/2016Morgan StanleySet Price TargetHold$47.00N/A
8/18/2016Robert W. BairdBoost Price TargetOutperform$48.00 ➝ $52.00N/A
8/18/2016The Goldman Sachs GroupReiterated RatingBuy$50.00N/A
8/18/2016Evercore ISIBoost Price TargetBuy$50.00 ➝ $53.00N/A
8/18/2016CowenBoost Price TargetOutperform$49.00 ➝ $51.00N/A
8/18/2016BTIG ResearchReiterated RatingBuy$55.00N/A
7/22/2016BTIG ResearchInitiated CoverageBuy$55.00N/A
6/30/2016SVB LeerinkReiterated RatingOutperform$51.00N/A
(Data available from 6/21/2016 forward)
Agilent Technologies logo
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $145.01
Low: $144.94
High: $146.83

50 Day Range

MA: $135.44
Low: $128.64
High: $146.92

52 Week Range

Now: $145.01
Low: $84.80
High: $147.68

Volume

3,220,600 shs

Average Volume

1,626,728 shs

Market Capitalization

$44.00 billion

P/E Ratio

48.66

Dividend Yield

0.54%

Beta

1

Frequently Asked Questions

What sell-side analysts currently cover shares of Agilent Technologies?

The following equities research analysts have issued stock ratings on Agilent Technologies in the last year: Atlantic Securities, Bank of America Co., Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cleveland Research, Cowen Inc, Credit Suisse Group AG, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Mizuho, MKM Partners, Morgan Stanley, Needham & Company LLC, Redburn Partners, Robert W. Baird, Sanford C. Bernstein, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., UBS Group AG, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for A.

What is the current price target for Agilent Technologies?

19 Wall Street analysts have set twelve-month price targets for Agilent Technologies in the last year. Their average twelve-month price target is $112.09, suggesting a possible downside of 22.7%. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell has the highest price target set, predicting A will reach $160.00 in the next twelve months. HSBC Holdings plc has the lowest price target set, forecasting a price of $30.70 for Agilent Technologies in the next year.
View the latest price targets for A.

What is the current consensus analyst rating for Agilent Technologies?

Agilent Technologies currently has 4 hold ratings and 20 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe A will outperform the market and that investors should add to their positions of Agilent Technologies.
View the latest ratings for A.

What other companies compete with Agilent Technologies?

How do I contact Agilent Technologies' investor relations team?

Agilent Technologies' physical mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company's listed phone number is (800) 227-9770 and its investor relations email address is [email protected] The official website for Agilent Technologies is www.agilent.com.